Samlyn Capital, LLC Astrazeneca PLC Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $23.1 Million - $27.7 Million	-389,589 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $21.7 Million - $26.1 Million	389,589 New	389,589 $25.8 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $17.4 Million - $18.7 Million	-504,610 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $2.13 Million - $2.37 Million	64,656 Added 14.7%	504,610 $17.6 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $14.1 Million - $15.3 Million	439,954	439,954 $15.3 Million

1,359

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.